New Cucumber and New Cucumber combinations for immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

摘要

The present invention refers to cucumber, protein, nucleic acid and cell for immunotherapy. In particular, the present invention relates to immunotherapy against cancer. The present invention also relates to xanthomas of T lymphocytes associated with tumors, alone or in combination with other cucumbers associated with tumors. For example, these xanthomas can be used as active pharmacological principles in vaccine composition to stimulate anti-tumor immune response,Or stimulate pre living T lymphocytes and then transfer to the patient. Cucumbers are bound to molecules of the maximum histocompatibility (MHC) complex,Or cucumbers themselves, or antibody targets, soluble receptors of lymphocytes, and other combined molecules